Research Article
Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
Table 6
Annual percentages of chronic kidney disease patients treated with IV iron.
| | 2006 | 2007 | 2008 |
| | Hemodialysis | | | | | Total number of patients | 395 | 544 | 779 | | Iron sucrose (%) | 359 (91) | 514 (94) | 718 (92) | | Iron dextran (%) | 36 (9) | 30 (6) | 61 (8) |
| | Peritoneal dialysis | | | | | Total number of patients | 17 | 18 | 23 | | Iron sucrose (%) | 10 (41) | 16 (89) | 19 (83) | | Iron dextran (%) | 7 (59) | 2 (11) | 4 (17) |
| | Not on dialysis | | | | | Total number of patients | 1197 | 1516 | 2189 | | Iron sucrose (%) | 923 (77) | 1263 (83) | 1856 (85) | | Iron dextran (%) | 274 (23) | 253 (17) | 333 (15) |
|
|
